Loading
A phase 3 trial of Intraoperative radiotherapy in Glioma & glioblastoma, run by Universitätsmedizin Mannheim, active and no longer recruiting.
Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme is a phase 3 interventional study registered as NCT02685605 by Universitätsmedizin Mannheim, with 314 participants planned, started 2016-12-09 and due to reach its primary completion in 2025-11. Interventions recorded: Standard surgery, Intraoperative radiotherapy, Radiochemotherapy, Temozolomide. Conditions recorded: Glioblastoma.
Linked to the technology Intraoperative radiotherapy because the registry names it ("intraoperative radiotherapy") among its interventions and Glioma & glioblastoma among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Temozolomide, Glioma & glioblastoma and the tag pipeline.
Shares Temozolomide, Glioma & glioblastoma and the tag pipeline.
Shares Temozolomide, Glioma & glioblastoma and the tag pipeline.
Shares Temozolomide, Glioma & glioblastoma and the tag pipeline.
Shares Temozolomide, Glioma & glioblastoma and the tag pipeline.
Shares Temozolomide, Glioma & glioblastoma and the tag pipeline.
Shares Intraoperative radiotherapy (IORT) and the tag pipeline.
Shares Intraoperative radiotherapy (IORT) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/